MGI Brings AI-Powered Spatial Pathology to Europe
MGI Tech has launched its VisiOmics multiplex immunofluorescence platform commercially in Europe, adding automated tissue staining, imaging and AI-based analysis to its pathology portfolio. The system is aimed at research applications spanning spatial proteomics, tumor biology and digital pathology. MGI Tech is expanding its presence in European digital pathology with the commercial launch of VisiOmics…
